Navigation Links
American Physiological Society endorses report on random source dogs and cats
Date:10/29/2009

BETHESDA, Md.The American Physiological Society (APS; www.the-aps.org) announced today that it has endorsed the recommendation of a National Academy of Sciences* (NAS) report calling for the identification of new suppliers to replace Class B dealers as providers of random source dogs and cats for medical research.

"Class B" is a broad category of licensure required by the United States Department of Agriculture (USDA) that applies to individuals who buy and sell animals that they do not breed and raise themselves. There are currently about a dozen Class B dealers who provide dogs and cats for medical and veterinary research and training and the development of veterinary drugs. The APS says that "immediate actions" are needed to identify or develop new suppliers of random source dogs and cats so that these activities may continue without disruption. A statement adopted by the APS Council on October 26, 2009 (http://www.the-aps.org/pa/resources/policyStmnts/paPolicyStmnts_dogscats.htm) underscores the importance of dogs and cats as research subjects: "These animals remain critical for health research to alleviate serious and life-threatening conditions that afflict humans and animals," the statement said.

Background

Most of the dogs and cats needed for research are specifically bred for that purpose, but some non-purpose bred or "random source" animals are also needed because these animals exhibit traits that are difficult to replicate in purpose-bred animals. Very old animals or ones with pre-existing health conditions, and exposure to viruses, allergens, or parasites may be needed to study age-related conditions or diseases that cannot be artificially induced. At one time local animal control facilities were willing to make such animals available for research, but nearly two dozen states and many municipalitiesincluding many where the affected research is being donenow have laws prohibiting that practice.

The APS statement points out that the NAS report, Scientific and Humane Issues in the Use of Random Source Dogs and Cats in Research, "found strong evidence of an ongoing need for random source dogs and cats in several important areas of biomedical research." At the same time, the NAS report also found evidence that a small number of USDA-licensed Class B dog and cat dealers had a history of recurrent Animal Welfare Act violations. The NAS panel, which was charged with examining the use of random source dogs and cats in research funded by the National Institutes of Health, recommended that NIH-funded researchers obtain random source dogs and cats from other suppliers. It offered as alternatives purchasing animals from commercial breeders (licensed by USDA as "Class A" dealers), animal control facilities, and hobby breeders. It also suggested that researchers obtain animals from individuals willing to donate them for research. However, the panel recognized that in some cases these alternate suppliers may be unable to provide the animals needed so it also suggested that "additional effort" by the NIH was needed to identify and/or develop new mechanisms to replace the animals currently supplied by Class B dealers.

Other needs for random source dogs and cats

The APS noted that the NAS panel had only focused on NIH-funded biomedical research and "did not address other needs for random source dogs and cats, such as the development and testing of animal health products and medical devices, medical research funded by entities other than the NIH, and medical and veterinary training." Consequently, the APS recommends that, "in addition to whatever steps NIH may take to meet the needs of its funded investigators, other provisions must be made to ensure that needs for random source dogs and cats in other fields can also be met."


'/>"/>

Contact: Alice Ra'anan
araanan@the-aps.org
301-634-7105
American Physiological Society
Source:Eurekalert

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/13/2017)... of security: Biometric Face Matching software  Continue Reading ... ... match face pictures against each other or against large databases. The recognition of ... ... for biometric Face Matching on the market. The speed is at 100 million ...
(Date:3/7/2017)... 2017   HireVue , the leading provider of ... the best talent, faster, today announced the additions of ... and Diana Kucer as Chief Marketing Officer ... team poised to drive continued growth in the company,s ... of record bookings in 2017. "Companies worldwide ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)...   iSpecimen ®, the marketplace for ... Service (DPS), a full-service anatomic pathology reference lab ... States , has joined a program offered by ... (DHIN) to make human biospecimens and associated data available ... announced in 2015 as a collaboration between iSpecimen and ...
(Date:3/22/2017)... 2017   Boston Biomedical , an industry leader ... target cancer stemness pathways, today announced its Board of ... Chief Executive Officer, effective April 24, 2017. ... , M.D., FACP, who has led Boston Biomedical since ... leadership, Boston Biomedical has grown from a "garage startup" ...
Breaking Biology Technology: